The Food and Drug Administration’s approval of lecanemab, a new Alzheimer’s medication shown in clinical trials to reduce the disease slowly over time.
Neuroscience
Eliminating amyloid from the brain may prevent symptoms in those who are destined to acquire early-onset Alzheimer’s disease, according to a clinical experiment. This suggests the need for additional research.
The researchers created a highly effective conversion technique using mouse cells that can generate over ten neurons from a single skin cell.
Using a novel animal model of Alzheimer’s disease, the study raises the possibility of a breakthrough in therapeutic approaches.
A recent partnership between Georgia Tech and Northwestern University has created a new high-performance organic electrochemical neuron that responds in the same frequency range as human neurons, opening up new possibilities for the area.
The immune cells of the central nervous system are known as microglia. Because they remove poisons from the brain and central nervous system, microglia are essential for preserving neuronal function.
The active ingredient in the diabetes and weight-loss medications Wegovy and Ozempic is semaglutide, a glucagon-like peptide receptor (GLP-1R) molecule that reduces appetite and aids in blood sugar regulation in type 2 diabetes.
Brain lesions produced by major brain trauma or stroke can alter neuronal connections between the motor cortex, a critical brain area needed for coordinating voluntary movement, and the muscles.
The report states that vascular dementia is the second most frequent subtype of dementia after Alzheimer’s disease. Still, the two illnesses are different clinically.
Findings could inform artificial intelligence research by helping investigators determine how one could develop more distributed neural networks.
